Replies to post #437678 on Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

“On the credibility scale, the company is a 9 and the skeptics here are a zero.“

You’re entitled to believe what you want but if what you say were true the stock would be $50 instead of $5. The fact is that many people with no particular agenda have questioned Anavex’s reported results and remain deeply skeptical. One need only look at how the stock reacted after and since last year’s CTAD debacle as evidence. While it’s true that biotech stocks generally have been weak for quite a while, AVXL’s dismal performance since CTAD 2022 goes well beyond the XBI.

Good luck and DOG bless.

[LakeshoreLeo1953]

Not many times I agree with BC4, but here I MUST.
Labeling my conservatism "ultra" would bely my EVER taking
a position in a pre revenue bio.
Labeling Skepticism as "0%" is just pandering/invalid.

I have held an increasingly smaller % of my portfolio in AVXL since 2015.
It has been a calculated risk that entire time.
It has NOT been the same risk throughout.
At present, I find the Science still viable (if unproven) but Macro considerations
negative in a pre revenue/cost of money environment.